Clinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population
- PMID: 24454973
- PMCID: PMC3894183
- DOI: 10.1371/journal.pntd.0002643
Clinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population
Abstract
Introduction: In resource-poor areas, infectious diseases may be important causes of morbidity among individuals infected with the Human T-Lymphotropic Virus type 1 (HTLV-1). We report the clinical associations of HTLV-1 infection among socially disadvantaged Indigenous adults in central Australia.
Methodology and principal findings: HTLV-1 serological results for Indigenous adults admitted 1(st) January 2000 to 31(st) December 2010 were obtained from the Alice Springs Hospital pathology database. Infections, comorbid conditions and HTLV-1 related diseases were identified using ICD-10 AM discharge morbidity codes. Relevant pathology and imaging results were reviewed. Disease associations, admission rates and risk factors for death were compared according to HTLV-1 serostatus. HTLV-1 western blots were positive for 531 (33.3%) of 1595 Indigenous adults tested. Clinical associations of HTLV-1 infection included bronchiectasis (adjusted Risk Ratio, 1.35; 95% CI, 1.14-1.60), blood stream infections (BSI) with enteric organisms (aRR, 1.36; 95% CI, 1.05-1.77) and admission with strongyloidiasis (aRR 1.38; 95% CI, 1.16-1.64). After adjusting for covariates, HTLV-1 infection remained associated with increased numbers of BSI episodes (adjusted negative binomial regression, coefficient, 0.21; 95% CI, 0.02-0.41) and increased admission numbers with strongyloidiasis (coefficient, 0.563; 95% CI, 0.17-0.95) and respiratory conditions including asthma (coefficient, 0.99; 95% CI, 0.27-1.7), lower respiratory tract infections (coefficient, 0.19; 95% CI, 0.04-0.34) and bronchiectasis (coefficient, 0.60; 95% CI, 0.02-1.18). Two patients were admitted with adult T-cell Leukemia/Lymphoma, four with probable HTLV-1 associated myelopathy and another with infective dermatitis. Independent predictors of mortality included BSI with enteric organisms (aRR 1.78; 95% CI, 1.15-2.74) and bronchiectasis (aRR 2.07; 95% CI, 1.45-2.98).
Conclusion: HTLV-1 infection contributes to morbidity among socially disadvantaged Indigenous adults in central Australia. This is largely due to an increased risk of other infections and respiratory disease. The spectrum of HTLV-1 related diseases may vary according to the social circumstances of the affected population.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures

Similar articles
-
Higher HTLV-1c proviral loads are associated with blood stream infections in an Indigenous Australian population.J Clin Virol. 2016 May;78:93-8. doi: 10.1016/j.jcv.2016.03.006. Epub 2016 Mar 11. J Clin Virol. 2016. PMID: 27011343
-
Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study.BMC Public Health. 2016 Aug 15;16:787. doi: 10.1186/s12889-016-3366-5. BMC Public Health. 2016. PMID: 27526923 Free PMC article.
-
Human T-Lymphotropic Virus type 1c subtype proviral loads, chronic lung disease and survival in a prospective cohort of Indigenous Australians.PLoS Negl Trop Dis. 2018 Mar 12;12(3):e0006281. doi: 10.1371/journal.pntd.0006281. eCollection 2018 Mar. PLoS Negl Trop Dis. 2018. PMID: 29529032 Free PMC article.
-
Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies.Lancet Infect Dis. 2020 Jan;20(1):133-143. doi: 10.1016/S1473-3099(19)30402-5. Epub 2019 Oct 21. Lancet Infect Dis. 2020. PMID: 31648940
-
Seroepidemiology of HTLV-I/II in Argentina: an overview.J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):301-8. doi: 10.1097/00126334-200403010-00012. J Acquir Immune Defic Syndr. 2004. PMID: 15076246 Review.
Cited by
-
High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease.BMC Infect Dis. 2015 Jul 6;15:258. doi: 10.1186/s12879-015-1002-0. BMC Infect Dis. 2015. PMID: 26143070 Free PMC article.
-
The 'ABC' of respiratory disorders among adult Indigenous people: asthma, bronchiectasis and COPD among Aboriginal Australians - a systematic review.BMJ Open Respir Res. 2023 Jul;10(1):e001738. doi: 10.1136/bmjresp-2023-001738. BMJ Open Respir Res. 2023. PMID: 37451702 Free PMC article.
-
A Qualitative Study Exploring Perceptions to the Human T Cell Leukaemia Virus Type 1 in Central Australia: Barriers to Preventing Transmission in a Remote Aboriginal Population.Front Med (Lausanne). 2022 Apr 29;9:845594. doi: 10.3389/fmed.2022.845594. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572972 Free PMC article.
-
40 years of the human T-cell leukemia virus: past, present, and future.F1000Res. 2019 Feb 28;8:F1000 Faculty Rev-228. doi: 10.12688/f1000research.17479.1. eCollection 2019. F1000Res. 2019. PMID: 30854194 Free PMC article. Review.
-
Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection.Retrovirology. 2021 Jan 6;18(1):1. doi: 10.1186/s12977-020-00543-z. Retrovirology. 2021. PMID: 33407607 Free PMC article. Review.
References
-
- Verdonck K, Gonzalez E, Van Dooren S, Vandamme A, Vanham G, et al. (2007) Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 7: 266–281. - PubMed
-
- Gessain A, Cassar O (2012) Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 3: 388 doi: 10.3389/fmicb.2012.00388 - DOI - PMC - PubMed
-
- Shimoyama M (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia/lymphoma. A report from the lymphoma study group. Br J Haematol 79: 428–437. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources